//
Seattle Heart Failure and Proportional Risk Models Predict Benefit From Implantable Cardioverter-Defibrillators
Association of Reduced Apical Untwisting With Incident HF in Asymptomatic Patients With HF Risk Factors
Positive recommendation for angiotensin receptor/neprilysin inhibitor: First medication approval for heart failure without "reduced ejection fraction"
Myofibroblast Phenotype and Reversibility of Fibrosis in Patients With End-Stage Heart Failure
Evaluation and Management of Right-Sided Heart Failure: A Scientific Statement From the American Heart Association
Ranolazine in High-Risk Patients With Implanted Cardioverter-Defibrillators - The RAID Trial
The Management of Atrial Fibrillation in Heart Failure: An Expert Panel Consensus
Cardiovascular Aging and Heart Failure: JACC Review Topic of the Week